

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.22119287 |
| 2 | regulation of response to tumor cell (GO:0002834) | 4.08994429 |
| 3 | positive regulation of response to tumor cell (GO:0002836) | 4.08994429 |
| 4 | positive regulation of immune response to tumor cell (GO:0002839) | 4.08994429 |
| 5 | regulation of immune response to tumor cell (GO:0002837) | 4.08994429 |
| 6 | urea cycle (GO:0000050) | 3.99071853 |
| 7 | urea metabolic process (GO:0019627) | 3.99071853 |
| 8 | pore complex assembly (GO:0046931) | 3.94649202 |
| 9 | growth hormone receptor signaling pathway (GO:0060396) | 3.80341286 |
| 10 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.79879821 |
| 11 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.73737573 |
| 12 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.73737573 |
| 13 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.73737573 |
| 14 | necroptotic process (GO:0070266) | 3.71978026 |
| 15 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.63523226 |
| 16 | proline biosynthetic process (GO:0006561) | 3.55131987 |
| 17 | regulation of RNA export from nucleus (GO:0046831) | 3.52571748 |
| 18 | nitrogen cycle metabolic process (GO:0071941) | 3.41728616 |
| 19 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.38812595 |
| 20 | cysteine metabolic process (GO:0006534) | 3.36351154 |
| 21 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.32463963 |
| 22 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.27402400 |
| 23 | COPII vesicle coating (GO:0048208) | 3.23894888 |
| 24 | histone H2A monoubiquitination (GO:0035518) | 3.23791260 |
| 25 | mitotic sister chromatid cohesion (GO:0007064) | 3.22855933 |
| 26 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.21970484 |
| 27 | nerve growth factor signaling pathway (GO:0038180) | 3.20906800 |
| 28 | Rap protein signal transduction (GO:0032486) | 3.18245914 |
| 29 | cellular response to growth hormone stimulus (GO:0071378) | 3.18002612 |
| 30 | protein localization to microtubule (GO:0035372) | 3.13325566 |
| 31 | L-phenylalanine catabolic process (GO:0006559) | 3.12101962 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.12101962 |
| 33 | chondrocyte development (GO:0002063) | 3.09127385 |
| 34 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.07304506 |
| 35 | acrosome assembly (GO:0001675) | 3.05843264 |
| 36 | negative regulation of cholesterol transport (GO:0032375) | 3.05830465 |
| 37 | negative regulation of sterol transport (GO:0032372) | 3.05830465 |
| 38 | negative regulation of interleukin-17 production (GO:0032700) | 3.05464941 |
| 39 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.05136149 |
| 40 | negative regulation of fibrinolysis (GO:0051918) | 3.04980509 |
| 41 | alpha-linolenic acid metabolic process (GO:0036109) | 3.00735005 |
| 42 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.00472073 |
| 43 | NLS-bearing protein import into nucleus (GO:0006607) | 3.00393755 |
| 44 | regulation of cholesterol homeostasis (GO:2000188) | 2.99121595 |
| 45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.99071296 |
| 46 | L-phenylalanine metabolic process (GO:0006558) | 2.99071296 |
| 47 | necrotic cell death (GO:0070265) | 2.98900353 |
| 48 | regulation of Rac protein signal transduction (GO:0035020) | 2.98641141 |
| 49 | regulation of histone H3-K9 methylation (GO:0051570) | 2.96604389 |
| 50 | nuclear pore complex assembly (GO:0051292) | 2.96427164 |
| 51 | phospholipid homeostasis (GO:0055091) | 2.92515191 |
| 52 | protein targeting to Golgi (GO:0000042) | 2.88056160 |
| 53 | drug catabolic process (GO:0042737) | 2.86027265 |
| 54 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.84594069 |
| 55 | sulfur amino acid catabolic process (GO:0000098) | 2.83586962 |
| 56 | protein carboxylation (GO:0018214) | 2.82631880 |
| 57 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.82631880 |
| 58 | lysine metabolic process (GO:0006553) | 2.82147956 |
| 59 | lysine catabolic process (GO:0006554) | 2.82147956 |
| 60 | iron ion import (GO:0097286) | 2.82139682 |
| 61 | protein localization to chromosome, centromeric region (GO:0071459) | 2.81848537 |
| 62 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.81740259 |
| 63 | cellular response to ethanol (GO:0071361) | 2.80207981 |
| 64 | complement activation, alternative pathway (GO:0006957) | 2.79903040 |
| 65 | programmed necrotic cell death (GO:0097300) | 2.79796132 |
| 66 | interkinetic nuclear migration (GO:0022027) | 2.78880468 |
| 67 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.77956382 |
| 68 | clathrin coat assembly (GO:0048268) | 2.77650008 |
| 69 | early endosome to late endosome transport (GO:0045022) | 2.76908052 |
| 70 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.76215777 |
| 71 | kynurenine metabolic process (GO:0070189) | 2.76157604 |
| 72 | homocysteine metabolic process (GO:0050667) | 2.74470200 |
| 73 | hippo signaling (GO:0035329) | 2.74081055 |
| 74 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.73392164 |
| 75 | aromatic amino acid family catabolic process (GO:0009074) | 2.73171445 |
| 76 | protein-lipid complex assembly (GO:0065005) | 2.73085686 |
| 77 | megakaryocyte development (GO:0035855) | 2.73002731 |
| 78 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.72598813 |
| 79 | establishment of protein localization to Golgi (GO:0072600) | 2.72478321 |
| 80 | epithelial cell-cell adhesion (GO:0090136) | 2.71641106 |
| 81 | regulation of protein activation cascade (GO:2000257) | 2.70578432 |
| 82 | vesicle coating (GO:0006901) | 2.67865561 |
| 83 | pre-miRNA processing (GO:0031054) | 2.67461255 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.66625372 |
| 85 | hepatocyte apoptotic process (GO:0097284) | 2.66088939 |
| 86 | negative regulation of lipid transport (GO:0032369) | 2.66031589 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 2.66006028 |
| 88 | serine family amino acid catabolic process (GO:0009071) | 2.64656049 |
| 89 | histone H3-K36 demethylation (GO:0070544) | 2.64204538 |
| 90 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.64132737 |
| 91 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.63589524 |
| 92 | regulation of sister chromatid cohesion (GO:0007063) | 2.61040457 |
| 93 | cell adhesion mediated by integrin (GO:0033627) | 2.60322977 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 2.60234387 |
| 95 | high-density lipoprotein particle remodeling (GO:0034375) | 2.60116406 |
| 96 | reverse cholesterol transport (GO:0043691) | 2.59770961 |
| 97 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.56626122 |
| 98 | protein localization to endosome (GO:0036010) | 2.56584029 |
| 99 | urate metabolic process (GO:0046415) | 2.55880826 |
| 100 | glycoprotein catabolic process (GO:0006516) | 2.54707956 |
| 101 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.54576366 |
| 102 | protein localization to microtubule cytoskeleton (GO:0072698) | 2.54347520 |
| 103 | mesodermal cell differentiation (GO:0048333) | 2.54297686 |
| 104 | embryonic process involved in female pregnancy (GO:0060136) | 2.54143737 |
| 105 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.53502879 |
| 106 | regulation of triglyceride catabolic process (GO:0010896) | 2.53166496 |
| 107 | histone lysine demethylation (GO:0070076) | 2.52580740 |
| 108 | phospholipid efflux (GO:0033700) | 2.52153508 |
| 109 | response to growth hormone (GO:0060416) | 2.52108716 |
| 110 | mitotic chromosome condensation (GO:0007076) | 2.51845063 |
| 111 | regulation of complement activation (GO:0030449) | 2.51667696 |
| 112 | protein localization to kinetochore (GO:0034501) | 2.51656767 |
| 113 | lymphoid progenitor cell differentiation (GO:0002320) | 2.51597474 |
| 114 | sphingosine metabolic process (GO:0006670) | 2.50703981 |
| 115 | regulation of fibrinolysis (GO:0051917) | 2.49936997 |
| 116 | corticosteroid receptor signaling pathway (GO:0031958) | 2.49427497 |
| 117 | plasma lipoprotein particle clearance (GO:0034381) | 2.48549254 |
| 118 | tryptophan metabolic process (GO:0006568) | 2.46970716 |
| 119 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.45799777 |
| 120 | definitive hemopoiesis (GO:0060216) | 2.43349394 |
| 121 | positive regulation of glycolytic process (GO:0045821) | 2.43286551 |
| 122 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.43011438 |
| 123 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.42956631 |
| 124 | positive regulation of protein autophosphorylation (GO:0031954) | 2.42440732 |
| 125 | positive regulation of chromosome segregation (GO:0051984) | 2.40471626 |
| 126 | protein targeting to vacuole (GO:0006623) | 2.39840733 |
| 127 | protein targeting to lysosome (GO:0006622) | 2.39840733 |
| 128 | establishment of protein localization to vacuole (GO:0072666) | 2.39840733 |
| 129 | epoxygenase P450 pathway (GO:0019373) | 2.39699936 |
| 130 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.38277218 |
| 131 | skin morphogenesis (GO:0043589) | 2.38234389 |
| 132 | tryptophan catabolic process (GO:0006569) | 2.38066945 |
| 133 | indole-containing compound catabolic process (GO:0042436) | 2.38066945 |
| 134 | indolalkylamine catabolic process (GO:0046218) | 2.38066945 |
| 135 | germ cell migration (GO:0008354) | 2.37563686 |
| 136 | viral entry into host cell (GO:0046718) | 2.37484935 |
| 137 | macroautophagy (GO:0016236) | 2.37268868 |
| 138 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.36931913 |
| 139 | regulation of bile acid biosynthetic process (GO:0070857) | 2.36670474 |
| 140 | bile acid biosynthetic process (GO:0006699) | 2.36029416 |
| 141 | thrombin receptor signaling pathway (GO:0070493) | 2.35176035 |
| 142 | cholesterol efflux (GO:0033344) | 2.34979908 |
| 143 | nuclear pore organization (GO:0006999) | 2.34978625 |
| 144 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.34928008 |
| 145 | negative regulation of histone methylation (GO:0031061) | 2.34916805 |
| 146 | regulation of transforming growth factor beta production (GO:0071634) | 2.34777441 |
| 147 | cytokine production involved in immune response (GO:0002367) | 2.34693363 |
| 148 | ether lipid metabolic process (GO:0046485) | 2.33796966 |
| 149 | low-density lipoprotein particle clearance (GO:0034383) | 2.33613719 |
| 150 | histone H3-K9 demethylation (GO:0033169) | 2.33445858 |
| 151 | histone demethylation (GO:0016577) | 2.33391602 |
| 152 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.33300694 |
| 153 | regulation of protein export from nucleus (GO:0046825) | 2.32198823 |
| 154 | bile acid metabolic process (GO:0008206) | 2.31716101 |
| 155 | response to lipoprotein particle (GO:0055094) | 2.31135604 |
| 156 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.31094062 |
| 157 | localization within membrane (GO:0051668) | 2.29301968 |
| 158 | membrane budding (GO:0006900) | 2.28965797 |
| 159 | magnesium ion transport (GO:0015693) | 2.28844148 |
| 160 | fibroblast migration (GO:0010761) | 2.28740930 |
| 161 | midgut development (GO:0007494) | 2.27673055 |
| 162 | triglyceride homeostasis (GO:0070328) | 2.27471305 |
| 163 | acylglycerol homeostasis (GO:0055090) | 2.27471305 |
| 164 | glutamate metabolic process (GO:0006536) | 2.27337757 |
| 165 | gastrulation with mouth forming second (GO:0001702) | 2.26451186 |
| 166 | negative regulation of DNA repair (GO:0045738) | 2.25706138 |
| 167 | tyrosine metabolic process (GO:0006570) | 2.25618085 |
| 168 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.25617385 |
| 169 | microtubule anchoring (GO:0034453) | 2.25476821 |
| 170 | morphogenesis of an epithelial sheet (GO:0002011) | 2.25417568 |
| 171 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.25337133 |
| 172 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.24740652 |
| 173 | stress fiber assembly (GO:0043149) | 2.23996398 |
| 174 | lipoprotein metabolic process (GO:0042157) | 2.23641580 |
| 175 | bile acid and bile salt transport (GO:0015721) | 2.23326069 |
| 176 | single strand break repair (GO:0000012) | 2.22412123 |
| 177 | regulation of histone H3-K27 methylation (GO:0061085) | 2.20283654 |
| 178 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.20110008 |
| 179 | Golgi to endosome transport (GO:0006895) | 2.19885953 |
| 180 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.19521084 |
| 181 | protein localization to chromosome (GO:0034502) | 2.19499100 |
| 182 | cellular response to fluid shear stress (GO:0071498) | 2.18042597 |
| 183 | cellular protein complex localization (GO:0034629) | 2.18019784 |
| 184 | myelin assembly (GO:0032288) | 2.17453910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.11953090 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.78746996 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.54517653 |
| 4 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.27532459 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.27434284 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.02926216 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.00564941 |
| 8 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.93108504 |
| 9 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.83172738 |
| 10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.79708090 |
| 11 | * STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.66879430 |
| 12 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.64277866 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.46484737 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.25957999 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.20075940 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.17060521 |
| 17 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.03803833 |
| 18 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.02880790 |
| 19 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.02880790 |
| 20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.94384481 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.78131787 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.76697443 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.76012771 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.75656699 |
| 25 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.70209046 |
| 26 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.69461810 |
| 27 | FUS_26573619_Chip-Seq_HEK293_Human | 1.69411124 |
| 28 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.69188728 |
| 29 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.67444625 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.65111486 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64630867 |
| 32 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.64128040 |
| 33 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60352521 |
| 34 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59396899 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.58434914 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.55631123 |
| 37 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.54694199 |
| 38 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.54466767 |
| 39 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.53665874 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.51789978 |
| 41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.50086431 |
| 42 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.49770999 |
| 43 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.48809557 |
| 44 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.48231960 |
| 45 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.47961146 |
| 46 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.47400885 |
| 47 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.47140343 |
| 48 | TP53_16413492_ChIP-PET_HCT116_Human | 1.45825501 |
| 49 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.45733561 |
| 50 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.44782275 |
| 51 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.44105868 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41793353 |
| 53 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.41553945 |
| 54 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.38652759 |
| 55 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.38513666 |
| 56 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.38327948 |
| 57 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.37343129 |
| 58 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.35430424 |
| 59 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.35246544 |
| 60 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.33779173 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33412748 |
| 62 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.32988215 |
| 63 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.32436180 |
| 64 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.32281640 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30054112 |
| 66 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.29523370 |
| 67 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.28961534 |
| 68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27553283 |
| 69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.26866266 |
| 70 | P300_19829295_ChIP-Seq_ESCs_Human | 1.26180868 |
| 71 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25090688 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25063543 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24964864 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23884514 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23750373 |
| 76 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.23225060 |
| 77 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.20299652 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20245378 |
| 79 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.19956243 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19512462 |
| 81 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19187821 |
| 82 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18366980 |
| 83 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17485172 |
| 84 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.16281802 |
| 85 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.16158610 |
| 86 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.15670372 |
| 87 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.15670372 |
| 88 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15414872 |
| 89 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15036673 |
| 90 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12379059 |
| 91 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11092558 |
| 92 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10967719 |
| 93 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10703736 |
| 94 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.10532982 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10022273 |
| 96 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.09764848 |
| 97 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08595406 |
| 98 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07330655 |
| 99 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07153646 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07086088 |
| 101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.07040394 |
| 102 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06050061 |
| 103 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06039672 |
| 104 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06029760 |
| 105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05794756 |
| 106 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.05512651 |
| 107 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05045030 |
| 108 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.04875599 |
| 109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04522532 |
| 110 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.04047085 |
| 111 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.03884476 |
| 112 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03630025 |
| 113 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.03622607 |
| 114 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03547557 |
| 115 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03109583 |
| 116 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02710967 |
| 117 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01972630 |
| 118 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01163335 |
| 119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00876993 |
| 120 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00335049 |
| 121 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00275200 |
| 122 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00268225 |
| 123 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.99938432 |
| 124 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99816447 |
| 125 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99716781 |
| 126 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99225576 |
| 127 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.98732771 |
| 128 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98570144 |
| 129 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.98391412 |
| 130 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98179612 |
| 131 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.98107706 |
| 132 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98064685 |
| 133 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97896861 |
| 134 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97795595 |
| 135 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.97592992 |
| 136 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.97418501 |
| 137 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97072864 |
| 138 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96999217 |
| 139 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95889820 |
| 140 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95258946 |
| 141 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95102263 |
| 142 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94891187 |
| 143 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94340120 |
| 144 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.94337229 |
| 145 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94081051 |
| 146 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93732306 |
| 147 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93574405 |
| 148 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93257963 |
| 149 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.91565026 |
| 150 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91543427 |
| 151 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91485600 |
| 152 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90495253 |
| 153 | MYC_22102868_ChIP-Seq_BL_Human | 0.90170276 |
| 154 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89416767 |
| 155 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89102229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.90243373 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.74362545 |
| 3 | MP0008057_abnormal_DNA_replication | 4.07577325 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.87335181 |
| 5 | MP0005365_abnormal_bile_salt | 3.83207408 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.42350924 |
| 7 | MP0002009_preneoplasia | 3.39214283 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 3.27459531 |
| 9 | MP0003300_gastrointestinal_ulcer | 3.13843386 |
| 10 | MP0003252_abnormal_bile_duct | 3.03174442 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.74187416 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.73080350 |
| 13 | MP0003656_abnormal_erythrocyte_physiolo | 2.65111682 |
| 14 | MP0006054_spinal_hemorrhage | 2.58981838 |
| 15 | MP0005076_abnormal_cell_differentiation | 2.49628416 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 2.26398120 |
| 17 | MP0003221_abnormal_cardiomyocyte_apopto | 2.20326864 |
| 18 | MP0004264_abnormal_extraembryonic_tissu | 2.11359299 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.03391327 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.00109579 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 1.98778692 |
| 22 | MP0003941_abnormal_skin_development | 1.98681286 |
| 23 | MP0005083_abnormal_biliary_tract | 1.98635983 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.89826648 |
| 25 | MP0010307_abnormal_tumor_latency | 1.79546165 |
| 26 | MP0005451_abnormal_body_composition | 1.77870127 |
| 27 | MP0001666_abnormal_nutrient_absorption | 1.75959604 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 1.74831128 |
| 29 | MP0001188_hyperpigmentation | 1.71316542 |
| 30 | MP0003890_abnormal_embryonic-extraembry | 1.64738788 |
| 31 | MP0000609_abnormal_liver_physiology | 1.62088702 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.59981642 |
| 33 | MP0008961_abnormal_basal_metabolism | 1.57375152 |
| 34 | MP0003943_abnormal_hepatobiliary_system | 1.57371343 |
| 35 | MP0009840_abnormal_foam_cell | 1.49946483 |
| 36 | MP0003303_peritoneal_inflammation | 1.49073971 |
| 37 | MP0003868_abnormal_feces_composition | 1.48165882 |
| 38 | MP0003828_pulmonary_edema | 1.47589610 |
| 39 | MP0005409_darkened_coat_color | 1.46759113 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.46189175 |
| 41 | MP0001849_ear_inflammation | 1.40403634 |
| 42 | MP0004957_abnormal_blastocyst_morpholog | 1.40371580 |
| 43 | MP0003315_abnormal_perineum_morphology | 1.39594000 |
| 44 | MP0004272_abnormal_basement_membrane | 1.38412704 |
| 45 | MP0003091_abnormal_cell_migration | 1.37788765 |
| 46 | MP0005248_abnormal_Harderian_gland | 1.37592786 |
| 47 | MP0009053_abnormal_anal_canal | 1.37467937 |
| 48 | MP0010678_abnormal_skin_adnexa | 1.30647887 |
| 49 | MP0002796_impaired_skin_barrier | 1.28869729 |
| 50 | MP0005187_abnormal_penis_morphology | 1.26970247 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.26493356 |
| 52 | MP0004883_abnormal_blood_vessel | 1.25580425 |
| 53 | MP0001915_intracranial_hemorrhage | 1.25223012 |
| 54 | MP0001879_abnormal_lymphatic_vessel | 1.24455264 |
| 55 | MP0000537_abnormal_urethra_morphology | 1.23187347 |
| 56 | MP0002254_reproductive_system_inflammat | 1.22769888 |
| 57 | MP0008004_abnormal_stomach_pH | 1.21904079 |
| 58 | MP0004084_abnormal_cardiac_muscle | 1.20952098 |
| 59 | MP0009697_abnormal_copulation | 1.19917179 |
| 60 | MP0003950_abnormal_plasma_membrane | 1.18113864 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.16981217 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.14628265 |
| 63 | MP0002928_abnormal_bile_duct | 1.13295878 |
| 64 | MP0002086_abnormal_extraembryonic_tissu | 1.13265715 |
| 65 | MP0005275_abnormal_skin_tensile | 1.11939956 |
| 66 | MP0001881_abnormal_mammary_gland | 1.10343332 |
| 67 | MP0000733_abnormal_muscle_development | 1.09498174 |
| 68 | MP0002168_other_aberrant_phenotype | 1.00698143 |
| 69 | MP0005621_abnormal_cell_physiology | 1.00515522 |
| 70 | MP0002084_abnormal_developmental_patter | 0.99557117 |
| 71 | MP0003448_altered_tumor_morphology | 0.99494449 |
| 72 | MP0002396_abnormal_hematopoietic_system | 0.99281817 |
| 73 | MP0005023_abnormal_wound_healing | 0.98562034 |
| 74 | MP0008932_abnormal_embryonic_tissue | 0.97841790 |
| 75 | MP0003195_calcinosis | 0.97073719 |
| 76 | MP0005380_embryogenesis_phenotype | 0.97068232 |
| 77 | MP0001672_abnormal_embryogenesis/_devel | 0.97068232 |
| 78 | MP0009384_cardiac_valve_regurgitation | 0.96751282 |
| 79 | MP0003115_abnormal_respiratory_system | 0.96723141 |
| 80 | MP0001191_abnormal_skin_condition | 0.96144091 |
| 81 | MP0002088_abnormal_embryonic_growth/wei | 0.95871786 |
| 82 | MP0004947_skin_inflammation | 0.95758550 |
| 83 | MP0003787_abnormal_imprinting | 0.94588894 |
| 84 | MP0003984_embryonic_growth_retardation | 0.93763557 |
| 85 | MP0005395_other_phenotype | 0.93642771 |
| 86 | MP0002118_abnormal_lipid_homeostasis | 0.93550598 |
| 87 | MP0001730_embryonic_growth_arrest | 0.93277266 |
| 88 | MP0009672_abnormal_birth_weight | 0.92906131 |
| 89 | MP0003077_abnormal_cell_cycle | 0.92487360 |
| 90 | MP0005408_hypopigmentation | 0.92378923 |
| 91 | MP0005332_abnormal_amino_acid | 0.91601938 |
| 92 | MP0002233_abnormal_nose_morphology | 0.91199514 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.91075991 |
| 94 | MP0000598_abnormal_liver_morphology | 0.90370100 |
| 95 | MP0000432_abnormal_head_morphology | 0.90335493 |
| 96 | MP0003755_abnormal_palate_morphology | 0.89770181 |
| 97 | MP0005501_abnormal_skin_physiology | 0.89082545 |
| 98 | MP0002098_abnormal_vibrissa_morphology | 0.88644886 |
| 99 | MP0004233_abnormal_muscle_weight | 0.88198789 |
| 100 | MP0004130_abnormal_muscle_cell | 0.88117890 |
| 101 | MP0000627_abnormal_mammary_gland | 0.87540671 |
| 102 | MP0005174_abnormal_tail_pigmentation | 0.86846254 |
| 103 | MP0003045_fibrosis | 0.86549835 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.85642871 |
| 105 | MP0000427_abnormal_hair_cycle | 0.84947631 |
| 106 | MP0003937_abnormal_limbs/digits/tail_de | 0.84387584 |
| 107 | MP0009278_abnormal_bone_marrow | 0.84241314 |
| 108 | MP0001727_abnormal_embryo_implantation | 0.83761823 |
| 109 | MP0000462_abnormal_digestive_system | 0.83412628 |
| 110 | MP0005220_abnormal_exocrine_pancreas | 0.80654261 |
| 111 | MP0009703_decreased_birth_body | 0.79699074 |
| 112 | MP0005164_abnormal_response_to | 0.78647135 |
| 113 | MP0004036_abnormal_muscle_relaxation | 0.78464560 |
| 114 | MP0001299_abnormal_eye_distance/ | 0.77939703 |
| 115 | MP0005384_cellular_phenotype | 0.77930105 |
| 116 | MP0001697_abnormal_embryo_size | 0.77325593 |
| 117 | MP0002006_tumorigenesis | 0.77044065 |
| 118 | MP0002877_abnormal_melanocyte_morpholog | 0.76803975 |
| 119 | MP0002092_abnormal_eye_morphology | 0.75648756 |
| 120 | MP0004197_abnormal_fetal_growth/weight/ | 0.75563514 |
| 121 | MP0002896_abnormal_bone_mineralization | 0.75523210 |
| 122 | MP0002085_abnormal_embryonic_tissue | 0.73802745 |
| 123 | MP0000383_abnormal_hair_follicle | 0.73145798 |
| 124 | MP0004484_altered_response_of | 0.72801241 |
| 125 | MP0002060_abnormal_skin_morphology | 0.72739944 |
| 126 | MP0003718_maternal_effect | 0.72161921 |
| 127 | MP0000767_abnormal_smooth_muscle | 0.71796545 |
| 128 | MP0001216_abnormal_epidermal_layer | 0.71607049 |
| 129 | MP0000428_abnormal_craniofacial_morphol | 0.71538088 |
| 130 | MP0000647_abnormal_sebaceous_gland | 0.71491084 |
| 131 | MP0000516_abnormal_urinary_system | 0.71282711 |
| 132 | MP0005367_renal/urinary_system_phenotyp | 0.71282711 |
| 133 | MP0005375_adipose_tissue_phenotype | 0.69984828 |
| 134 | MP0000377_abnormal_hair_follicle | 0.69748120 |
| 135 | MP0002971_abnormal_brown_adipose | 0.69628550 |
| 136 | MP0002697_abnormal_eye_size | 0.69123681 |
| 137 | MP0000467_abnormal_esophagus_morphology | 0.69041156 |
| 138 | MP0003699_abnormal_female_reproductive | 0.68938029 |
| 139 | MP0000579_abnormal_nail_morphology | 0.68566884 |
| 140 | MP0000604_amyloidosis | 0.68212765 |
| 141 | MP0002925_abnormal_cardiovascular_devel | 0.67631317 |
| 142 | MP0005257_abnormal_intraocular_pressure | 0.67536691 |
| 143 | MP0009780_abnormal_chondrocyte_physiolo | 0.67222857 |
| 144 | MP0000350_abnormal_cell_proliferation | 0.66893824 |
| 145 | MP0003935_abnormal_craniofacial_develop | 0.65591974 |
| 146 | MP0005647_abnormal_sex_gland | 0.62227396 |
| 147 | MP0009643_abnormal_urine_homeostasis | 0.61260049 |
| 148 | MP0002102_abnormal_ear_morphology | 0.59538025 |
| 149 | MP0005319_abnormal_enzyme/_coenzyme | 0.59378120 |
| 150 | MP0003121_genomic_imprinting | 0.57976678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.34975611 |
| 2 | Curly hair (HP:0002212) | 4.11416622 |
| 3 | Cortical dysplasia (HP:0002539) | 3.71352488 |
| 4 | Termporal pattern (HP:0011008) | 3.61871229 |
| 5 | Insidious onset (HP:0003587) | 3.61871229 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 3.43146808 |
| 7 | Deep philtrum (HP:0002002) | 3.41393931 |
| 8 | Absent frontal sinuses (HP:0002688) | 3.23208099 |
| 9 | Papillary thyroid carcinoma (HP:0002895) | 3.12886846 |
| 10 | Esophageal varix (HP:0002040) | 3.03147657 |
| 11 | Myocardial infarction (HP:0001658) | 3.01174871 |
| 12 | Spinal cord lesions (HP:0100561) | 2.90580314 |
| 13 | Syringomyelia (HP:0003396) | 2.90580314 |
| 14 | Abnormality of the fingertips (HP:0001211) | 2.89013992 |
| 15 | Subacute progressive viral hepatitis (HP:0006572) | 2.88489081 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.88100144 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 2.86604226 |
| 18 | Abnormal platelet volume (HP:0011876) | 2.82776131 |
| 19 | Cystic hygroma (HP:0000476) | 2.80380163 |
| 20 | Sparse lateral eyebrow (HP:0005338) | 2.74991197 |
| 21 | Xanthomatosis (HP:0000991) | 2.74701661 |
| 22 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.69621768 |
| 23 | Heterotopia (HP:0002282) | 2.67353362 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.65482979 |
| 25 | Epidermoid cyst (HP:0200040) | 2.62609915 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 2.60556432 |
| 27 | Complement deficiency (HP:0004431) | 2.59989616 |
| 28 | Hypolipoproteinemia (HP:0010981) | 2.57558240 |
| 29 | Rectal prolapse (HP:0002035) | 2.55780382 |
| 30 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.48554630 |
| 31 | Asymmetry of the thorax (HP:0001555) | 2.47193856 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.46206257 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 2.41167856 |
| 34 | Hepatocellular carcinoma (HP:0001402) | 2.40296036 |
| 35 | Scanning speech (HP:0002168) | 2.37580942 |
| 36 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.37292743 |
| 37 | Relative macrocephaly (HP:0004482) | 2.34016416 |
| 38 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.33459162 |
| 39 | Tetraparesis (HP:0002273) | 2.30890747 |
| 40 | Male infertility (HP:0003251) | 2.30470932 |
| 41 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.29169666 |
| 42 | Acanthocytosis (HP:0001927) | 2.29026578 |
| 43 | Back pain (HP:0003418) | 2.23828540 |
| 44 | Long toe (HP:0010511) | 2.23061942 |
| 45 | Spastic diplegia (HP:0001264) | 2.21952455 |
| 46 | Overgrowth (HP:0001548) | 2.18393509 |
| 47 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.16116238 |
| 48 | Pulmonic stenosis (HP:0001642) | 2.15647576 |
| 49 | Arterial tortuosity (HP:0005116) | 2.14701176 |
| 50 | Aortic aneurysm (HP:0004942) | 2.13797299 |
| 51 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.13100060 |
| 52 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.13100060 |
| 53 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.12877616 |
| 54 | Spondylolisthesis (HP:0003302) | 2.12500702 |
| 55 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.12436202 |
| 56 | Macroorchidism (HP:0000053) | 2.11169464 |
| 57 | Cubitus valgus (HP:0002967) | 2.10441709 |
| 58 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.10127825 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.09843185 |
| 60 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.08832196 |
| 61 | Subaortic stenosis (HP:0001682) | 2.08832196 |
| 62 | Abnormal auditory evoked potentials (HP:0006958) | 2.06908191 |
| 63 | Gastrointestinal carcinoma (HP:0002672) | 2.06632583 |
| 64 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.06632583 |
| 65 | Ankyloglossia (HP:0010296) | 2.05938513 |
| 66 | Neonatal hypoglycemia (HP:0001998) | 2.04848071 |
| 67 | Short middle phalanx of the 5th finger (HP:0004220) | 2.04264361 |
| 68 | Abnormality of purine metabolism (HP:0004352) | 2.02947993 |
| 69 | Mitral valve prolapse (HP:0001634) | 2.02929628 |
| 70 | Bladder neoplasm (HP:0009725) | 2.02667977 |
| 71 | Bladder carcinoma (HP:0002862) | 2.02667977 |
| 72 | Abnormality of nail color (HP:0100643) | 2.02637625 |
| 73 | Disinhibition (HP:0000734) | 2.02625790 |
| 74 | Shallow orbits (HP:0000586) | 2.02586752 |
| 75 | Conjunctival telangiectasia (HP:0000524) | 2.01775155 |
| 76 | Freckling (HP:0001480) | 2.01288412 |
| 77 | Abnormality of macular pigmentation (HP:0008002) | 2.01233244 |
| 78 | Metaphyseal dysplasia (HP:0100255) | 2.01210515 |
| 79 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.00540709 |
| 80 | Abnormality of the frontal sinuses (HP:0002687) | 2.00473405 |
| 81 | Central scotoma (HP:0000603) | 2.00386225 |
| 82 | Pelvic girdle muscle weakness (HP:0003749) | 2.00312832 |
| 83 | Dysmetric saccades (HP:0000641) | 1.99483210 |
| 84 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.97429522 |
| 85 | Pheochromocytoma (HP:0002666) | 1.95984433 |
| 86 | Hypercholesterolemia (HP:0003124) | 1.95481486 |
| 87 | Narrow palate (HP:0000189) | 1.95079012 |
| 88 | Volvulus (HP:0002580) | 1.94656881 |
| 89 | Spontaneous abortion (HP:0005268) | 1.94327220 |
| 90 | Cerebral aneurysm (HP:0004944) | 1.94254967 |
| 91 | Uterine leiomyosarcoma (HP:0002891) | 1.93955182 |
| 92 | Leiomyosarcoma (HP:0100243) | 1.93955182 |
| 93 | Enlarged penis (HP:0000040) | 1.93417925 |
| 94 | Aneurysm (HP:0002617) | 1.93120876 |
| 95 | Hematochezia (HP:0002573) | 1.92012517 |
| 96 | Large earlobe (HP:0009748) | 1.90581677 |
| 97 | Hip dysplasia (HP:0001385) | 1.90187832 |
| 98 | Exostoses (HP:0100777) | 1.89035527 |
| 99 | Biliary tract neoplasm (HP:0100574) | 1.88547110 |
| 100 | Lip pit (HP:0100267) | 1.86535632 |
| 101 | Shawl scrotum (HP:0000049) | 1.86183039 |
| 102 | Facial hemangioma (HP:0000329) | 1.86114987 |
| 103 | Thickened calvaria (HP:0002684) | 1.85355939 |
| 104 | Hyperglycemia (HP:0003074) | 1.85117680 |
| 105 | Vascular tortuosity (HP:0004948) | 1.83940055 |
| 106 | Oligodactyly (hands) (HP:0001180) | 1.82603403 |
| 107 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.82388896 |
| 108 | Gout (HP:0001997) | 1.81659644 |
| 109 | Abnormality of chromosome segregation (HP:0002916) | 1.79786992 |
| 110 | Hydroxyprolinuria (HP:0003080) | 1.79158520 |
| 111 | Abnormality of proline metabolism (HP:0010907) | 1.79158520 |
| 112 | Long clavicles (HP:0000890) | 1.79105519 |
| 113 | Rhabdomyosarcoma (HP:0002859) | 1.79043735 |
| 114 | Germ cell neoplasia (HP:0100728) | 1.78698146 |
| 115 | Increased number of teeth (HP:0011069) | 1.78519842 |
| 116 | Decreased skull ossification (HP:0004331) | 1.78219289 |
| 117 | Hypoplastic labia majora (HP:0000059) | 1.77301546 |
| 118 | Osteolytic defects of the hand bones (HP:0009699) | 1.77133520 |
| 119 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.77133520 |
| 120 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.76968485 |
| 121 | Increased density of long bones (HP:0006392) | 1.76475354 |
| 122 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.76207594 |
| 123 | Autoamputation (HP:0001218) | 1.75435068 |
| 124 | Sandal gap (HP:0001852) | 1.74935846 |
| 125 | Renal cell carcinoma (HP:0005584) | 1.74895847 |
| 126 | Striae distensae (HP:0001065) | 1.73141261 |
| 127 | Pseudobulbar signs (HP:0002200) | 1.72745606 |
| 128 | Right ventricular cardiomyopathy (HP:0011663) | 1.72689878 |
| 129 | Truncal obesity (HP:0001956) | 1.72452420 |
| 130 | Shoulder girdle muscle weakness (HP:0003547) | 1.72015236 |
| 131 | Acute myeloid leukemia (HP:0004808) | 1.71784405 |
| 132 | Upper motor neuron abnormality (HP:0002127) | 1.71718417 |
| 133 | Lymphangioma (HP:0100764) | 1.71704521 |
| 134 | Skin nodule (HP:0200036) | 1.71311290 |
| 135 | Acute lymphatic leukemia (HP:0006721) | 1.70927708 |
| 136 | Low posterior hairline (HP:0002162) | 1.69934649 |
| 137 | Embryonal renal neoplasm (HP:0011794) | 1.69855823 |
| 138 | Vertebral arch anomaly (HP:0008438) | 1.68847696 |
| 139 | Microglossia (HP:0000171) | 1.68029098 |
| 140 | Persistence of primary teeth (HP:0006335) | 1.67669674 |
| 141 | Peritonitis (HP:0002586) | 1.67054878 |
| 142 | Sensorimotor neuropathy (HP:0007141) | 1.66598692 |
| 143 | Inappropriate behavior (HP:0000719) | 1.66290269 |
| 144 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.65618854 |
| 145 | Abnormal foot bone ossification (HP:0010675) | 1.65415311 |
| 146 | Coarse hair (HP:0002208) | 1.64794990 |
| 147 | Abnormality of nucleobase metabolism (HP:0010932) | 1.64683100 |
| 148 | Prolonged partial thromboplastin time (HP:0003645) | 1.64620610 |
| 149 | Abnormality of complement system (HP:0005339) | 1.64582335 |
| 150 | Polycythemia (HP:0001901) | 1.63485063 |
| 151 | Abnormality of chromosome stability (HP:0003220) | 1.63379255 |
| 152 | Increased mean platelet volume (HP:0011877) | 1.63224984 |
| 153 | Thickened nuchal skin fold (HP:0000474) | 1.63214406 |
| 154 | Spontaneous hematomas (HP:0007420) | 1.63093550 |
| 155 | Focal segmental glomerulosclerosis (HP:0000097) | 1.62854915 |
| 156 | Neoplasm of the small intestine (HP:0100833) | 1.62801997 |
| 157 | Camptodactyly of toe (HP:0001836) | 1.62117187 |
| 158 | Thyroid carcinoma (HP:0002890) | 1.62007443 |
| 159 | Genetic anticipation (HP:0003743) | 1.61894103 |
| 160 | Abnormality of the labia majora (HP:0012881) | 1.61368553 |
| 161 | Oligodactyly (HP:0012165) | 1.60484379 |
| 162 | Cutis marmorata (HP:0000965) | 1.60163286 |
| 163 | Oligodontia (HP:0000677) | 1.60157639 |
| 164 | Cardiovascular calcification (HP:0011915) | 1.59015061 |
| 165 | Turricephaly (HP:0000262) | 1.58708952 |
| 166 | Midline defect of the nose (HP:0004122) | 1.58266320 |
| 167 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.57998161 |
| 168 | Short 4th metacarpal (HP:0010044) | 1.57998161 |
| 169 | Renovascular hypertension (HP:0100817) | 1.57409290 |
| 170 | Fat malabsorption (HP:0002630) | 1.56452650 |
| 171 | Vascular calcification (HP:0004934) | 1.55699616 |
| 172 | Hyperglycinemia (HP:0002154) | 1.55108248 |
| 173 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.55006360 |
| 174 | Abnormality of the nasal septum (HP:0000419) | 1.52949182 |
| 175 | Malnutrition (HP:0004395) | 1.52814925 |
| 176 | Ulnar bowing (HP:0003031) | 1.52018117 |
| 177 | Abnormality of the lower motor neuron (HP:0002366) | 1.51649779 |
| 178 | Hemorrhage of the eye (HP:0011885) | 1.50852139 |
| 179 | Joint hemorrhage (HP:0005261) | 1.50101369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 5.18382098 |
| 2 | TRPM7 | 3.95923693 |
| 3 | CDK12 | 3.38577361 |
| 4 | ERBB3 | 2.88128242 |
| 5 | LATS2 | 2.69659097 |
| 6 | TRIB3 | 2.67373506 |
| 7 | TAOK3 | 2.57553605 |
| 8 | EIF2AK3 | 2.54407685 |
| 9 | TRIM28 | 2.53538458 |
| 10 | PKN2 | 2.41038598 |
| 11 | SIK1 | 2.35563489 |
| 12 | STK3 | 2.27781689 |
| 13 | AKT3 | 2.19585871 |
| 14 | CASK | 2.10842406 |
| 15 | EEF2K | 2.08532533 |
| 16 | IRAK1 | 2.07675043 |
| 17 | BRSK2 | 2.06179596 |
| 18 | FRK | 1.97568381 |
| 19 | CAMK1D | 1.97180217 |
| 20 | PTK6 | 1.96882407 |
| 21 | BCR | 1.92384067 |
| 22 | BMPR2 | 1.90974259 |
| 23 | FGFR4 | 1.89663144 |
| 24 | ACVR1B | 1.79439892 |
| 25 | DMPK | 1.78634849 |
| 26 | YES1 | 1.77936160 |
| 27 | STK10 | 1.73663821 |
| 28 | STK38L | 1.72624435 |
| 29 | DYRK3 | 1.66031516 |
| 30 | RIPK1 | 1.64903054 |
| 31 | ERBB4 | 1.63002743 |
| 32 | FGFR3 | 1.58764345 |
| 33 | CAMK1G | 1.57288982 |
| 34 | MATK | 1.56175820 |
| 35 | MST4 | 1.55164620 |
| 36 | EIF2AK1 | 1.53928732 |
| 37 | WEE1 | 1.53152761 |
| 38 | SIK3 | 1.50243315 |
| 39 | MAP3K12 | 1.48725310 |
| 40 | ERN1 | 1.46357670 |
| 41 | STK24 | 1.45527355 |
| 42 | CDK6 | 1.43358791 |
| 43 | MKNK1 | 1.42580466 |
| 44 | NEK2 | 1.41716296 |
| 45 | TAOK1 | 1.40265611 |
| 46 | TNIK | 1.35454527 |
| 47 | RET | 1.28557606 |
| 48 | MAP3K10 | 1.25216274 |
| 49 | MAP3K9 | 1.25142514 |
| 50 | FGFR2 | 1.23160942 |
| 51 | CDC7 | 1.22420135 |
| 52 | EPHA2 | 1.21701321 |
| 53 | MKNK2 | 1.18717220 |
| 54 | PDGFRA | 1.15398503 |
| 55 | PDGFRB | 1.14455968 |
| 56 | MAP3K2 | 1.14199502 |
| 57 | LMTK2 | 1.14080179 |
| 58 | MTOR | 1.10169868 |
| 59 | KSR2 | 1.05637974 |
| 60 | MAP3K6 | 1.04675160 |
| 61 | MELK | 1.02867539 |
| 62 | PTK2 | 1.01582063 |
| 63 | NUAK1 | 1.01250097 |
| 64 | JAK1 | 1.00601163 |
| 65 | TYRO3 | 0.99559597 |
| 66 | EPHA3 | 0.97103904 |
| 67 | PNCK | 0.96902563 |
| 68 | ILK | 0.94833095 |
| 69 | SGK3 | 0.93989789 |
| 70 | MAP3K14 | 0.92050041 |
| 71 | EPHB1 | 0.89714644 |
| 72 | KSR1 | 0.89299720 |
| 73 | TTN | 0.89102546 |
| 74 | MET | 0.88119002 |
| 75 | CDK9 | 0.87891444 |
| 76 | MAP2K7 | 0.84513278 |
| 77 | PIK3CG | 0.84362747 |
| 78 | FER | 0.83796871 |
| 79 | RPS6KB1 | 0.82260680 |
| 80 | TTK | 0.82022165 |
| 81 | FLT3 | 0.81652451 |
| 82 | LRRK2 | 0.79962584 |
| 83 | PLK3 | 0.79154914 |
| 84 | STK39 | 0.79008107 |
| 85 | DDR2 | 0.78359754 |
| 86 | JAK2 | 0.76999254 |
| 87 | FGFR1 | 0.76751858 |
| 88 | PRKAA2 | 0.76293593 |
| 89 | NLK | 0.74696501 |
| 90 | NEK9 | 0.73857191 |
| 91 | ERBB2 | 0.73735254 |
| 92 | PRKAA1 | 0.72899350 |
| 93 | CHUK | 0.72340083 |
| 94 | CLK1 | 0.71352314 |
| 95 | SIK2 | 0.69021318 |
| 96 | CAMKK2 | 0.68356290 |
| 97 | JAK3 | 0.68107651 |
| 98 | SCYL2 | 0.64647976 |
| 99 | TSSK6 | 0.64453608 |
| 100 | RAF1 | 0.64283017 |
| 101 | STK38 | 0.64278786 |
| 102 | TYK2 | 0.63553259 |
| 103 | MAP3K8 | 0.61435578 |
| 104 | MST1R | 0.61334635 |
| 105 | IRAK2 | 0.60372602 |
| 106 | SGK2 | 0.59015973 |
| 107 | MAP2K4 | 0.58877347 |
| 108 | PAK4 | 0.57134138 |
| 109 | MAP3K7 | 0.56200740 |
| 110 | MAP3K4 | 0.55890720 |
| 111 | EPHB2 | 0.55881810 |
| 112 | PAK2 | 0.54506467 |
| 113 | CSNK1D | 0.51156217 |
| 114 | EGFR | 0.50250481 |
| 115 | EIF2AK2 | 0.49855599 |
| 116 | NEK6 | 0.48775510 |
| 117 | BMX | 0.48630104 |
| 118 | MARK2 | 0.48393716 |
| 119 | PBK | 0.47820414 |
| 120 | CDK4 | 0.47655775 |
| 121 | PLK2 | 0.47549047 |
| 122 | BRD4 | 0.47413606 |
| 123 | FGR | 0.46662992 |
| 124 | ALK | 0.46406078 |
| 125 | MAP3K5 | 0.45260467 |
| 126 | ATM | 0.44800421 |
| 127 | RPS6KB2 | 0.44694936 |
| 128 | CHEK2 | 0.43988953 |
| 129 | PAK6 | 0.42511523 |
| 130 | RPS6KA4 | 0.41435168 |
| 131 | ROCK1 | 0.40539950 |
| 132 | CSNK1G1 | 0.39630982 |
| 133 | MARK3 | 0.38645847 |
| 134 | GSK3A | 0.38340621 |
| 135 | MAPK11 | 0.38202149 |
| 136 | MOS | 0.37898347 |
| 137 | STK11 | 0.36736274 |
| 138 | TGFBR1 | 0.36161324 |
| 139 | ITK | 0.35404599 |
| 140 | CHEK1 | 0.35284862 |
| 141 | ABL1 | 0.34989651 |
| 142 | MAPK10 | 0.33921929 |
| 143 | IGF1R | 0.33347374 |
| 144 | TGFBR2 | 0.32926213 |
| 145 | DYRK1B | 0.32704849 |
| 146 | CSK | 0.32548954 |
| 147 | PLK4 | 0.32266440 |
| 148 | BRAF | 0.32122338 |
| 149 | IRAK3 | 0.31924043 |
| 150 | CSNK1A1L | 0.31804198 |
| 151 | PIK3CA | 0.29415024 |
| 152 | PAK3 | 0.28755494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55888488 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.47848084 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.43470923 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.42015802 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.40366393 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.96958929 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87691915 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83341924 |
| 9 | Lysine degradation_Homo sapiens_hsa00310 | 1.80399463 |
| 10 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.64356475 |
| 11 | Thyroid cancer_Homo sapiens_hsa05216 | 1.63589572 |
| 12 | Adherens junction_Homo sapiens_hsa04520 | 1.53648664 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50552037 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.47290839 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.44705377 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.40992311 |
| 17 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35692605 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.34615188 |
| 19 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.32108924 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30498955 |
| 21 | Platelet activation_Homo sapiens_hsa04611 | 1.29437795 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24435446 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.23639150 |
| 24 | Insulin resistance_Homo sapiens_hsa04931 | 1.19421141 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.19130737 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.18746413 |
| 27 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.16884842 |
| 28 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.13945577 |
| 29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.13315764 |
| 30 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.13205315 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.10620085 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10153149 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08453734 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08405576 |
| 35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08268423 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.05867306 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03899130 |
| 38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02859706 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.01982202 |
| 40 | Melanoma_Homo sapiens_hsa05218 | 0.99719254 |
| 41 | Endometrial cancer_Homo sapiens_hsa05213 | 0.99262840 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99074282 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.98451513 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95632303 |
| 45 | Cell cycle_Homo sapiens_hsa04110 | 0.94541543 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94043773 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.93674934 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93157358 |
| 49 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93050892 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91531994 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91195199 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90615412 |
| 53 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.88429411 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87694185 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.86566020 |
| 56 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86047800 |
| 57 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.85904945 |
| 58 | Axon guidance_Homo sapiens_hsa04360 | 0.84603273 |
| 59 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.84471345 |
| 60 | Colorectal cancer_Homo sapiens_hsa05210 | 0.84212534 |
| 61 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84042789 |
| 62 | Measles_Homo sapiens_hsa05162 | 0.83547754 |
| 63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82616852 |
| 64 | Malaria_Homo sapiens_hsa05144 | 0.82600116 |
| 65 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82260637 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82195598 |
| 67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81961479 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81888963 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.81208135 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.78860239 |
| 71 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.78785756 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78517021 |
| 73 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77933066 |
| 74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.77405211 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77034149 |
| 76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76055892 |
| 77 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.76053345 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75722528 |
| 79 | Focal adhesion_Homo sapiens_hsa04510 | 0.75371365 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 0.74920064 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73275244 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73035488 |
| 83 | Pathways in cancer_Homo sapiens_hsa05200 | 0.72987379 |
| 84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72562019 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71965684 |
| 86 | Gap junction_Homo sapiens_hsa04540 | 0.71629499 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70793317 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70569793 |
| 89 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70128074 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69868412 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68930738 |
| 92 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.68633614 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.68300670 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67347848 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67186033 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66730669 |
| 97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66710322 |
| 98 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.65955681 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65908736 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65313278 |
| 101 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65046699 |
| 102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64575121 |
| 103 | Basal transcription factors_Homo sapiens_hsa03022 | 0.63673926 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.62795981 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.62625544 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62410228 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.60320423 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59972868 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59876337 |
| 110 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59591229 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59531886 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59133806 |
| 113 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58834766 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58797827 |
| 115 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.56844271 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56714921 |
| 117 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55902226 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55354795 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55168001 |
| 120 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55096146 |
| 121 | Peroxisome_Homo sapiens_hsa04146 | 0.54883751 |
| 122 | Hepatitis B_Homo sapiens_hsa05161 | 0.54881370 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53891065 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.53871220 |
| 125 | Hepatitis C_Homo sapiens_hsa05160 | 0.53459850 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | 0.51792115 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51280356 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50817182 |
| 129 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50795993 |
| 130 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50274935 |
| 131 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49941355 |
| 132 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49798505 |
| 133 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.49447717 |
| 134 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48257162 |
| 135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47872242 |
| 136 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.47232353 |
| 137 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46506736 |
| 138 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.44728471 |
| 139 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43109425 |
| 140 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43083542 |
| 141 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42308182 |
| 142 | Tight junction_Homo sapiens_hsa04530 | 0.41705268 |
| 143 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40901891 |
| 144 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40725335 |
| 145 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40215117 |
| 146 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38839338 |
| 147 | Influenza A_Homo sapiens_hsa05164 | 0.38470279 |
| 148 | Circadian rhythm_Homo sapiens_hsa04710 | 0.38305131 |

